Hexagon Capital Partners LLC Eli Lilly & CO Transaction History

Hexagon Capital Partners LLC

$508 Million
Q3 2024

A detailed history of Hexagon Capital Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 703 shares of LLY stock, worth $575,707. This represents 0.12% of its overall portfolio holdings.

Number of Shares

703

Previous 744 5.51%

Holding current value

$575,707

Previous $673,000 7.58%

% of portfolio

0.12%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$772.14 - $960.02 $31,657 - $39,360	-41 Reduced 5.51%	703 $622,000
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $17,396 - $21,816	24 Added 3.33%	744 $673,000
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $47,968 - $64,174	81 Added 12.68%	720 $560,000
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $26,784 - $31,575	51 Added 8.67%	639 $372,000
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $20,430 - $28,167	-47 Reduced 7.4%	588 $315,000
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $1,753 - $2,344	-5 Reduced 0.78%	635 $297,000
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $2,174 - $2,553	7 Added 1.11%	640 $219,000
Q4 2022 Jan 13, 2023	BUY	$321.55 - $374.67 $9,003 - $10,490	28 Added 4.63%	633 $0
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $17,788 - $20,272	60 Added 11.01%	605 $196,000
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $55,188 - $64,799	-198 Reduced 26.65%	545 $177,000
Q1 2022 Apr 13, 2022	SELL	$234.69 - $291.66 $11,030 - $13,708	-47 Reduced 5.95%	743 $213,000
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $20,911 - $25,950	-93 Reduced 10.53%	790 $218,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $18,392 - $22,634	83 Added 10.38%	883 $204,000
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $18,055 - $23,354	-100 Reduced 11.11%	800 $184,000
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $92,019 - $119,123	-560 Reduced 38.36%	900 $168,000
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $9,132 - $12,084	-70 Reduced 4.58%	1,460 $246,000
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $223,716 - $258,768	1,530 New	1,530 $201,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Account

Hexagon Capital Partners LLC Eli Lilly & CO Transaction History